Advertisement
Research ArticleEndocrine and Diabetes

KGA-2727, a novel selective inhibitor of high-affinity sodium glucose cotransporter (SGLT1), exhibits antidiabetic efficacy in rodent models.

Toshihide Shibazaki, Masaki Tomae, Yukiko Ishikawa-Takemura, Nobuhiko Fushimi, Fumiaki Itoh, Mitsuhiko Yamada and Masayuki Isaji
Journal of Pharmacology and Experimental Therapeutics April 26, 2012, jpet.112.193045; DOI: https://doi.org/10.1124/jpet.112.193045
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleEndocrine and Diabetes

KGA-2727, a novel selective inhibitor of high-affinity sodium glucose cotransporter (SGLT1), exhibits antidiabetic efficacy in rodent models.

Toshihide Shibazaki, Masaki Tomae, Yukiko Ishikawa-Takemura, Nobuhiko Fushimi, Fumiaki Itoh, Mitsuhiko Yamada and Masayuki Isaji
Journal of Pharmacology and Experimental Therapeutics April 26, 2012, jpet.112.193045; DOI: https://doi.org/10.1124/jpet.112.193045
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement